Handbook of Cannabis

Research output: Book/ReportBook

Abstract

This book provides a multifaceted account of cannabis, a plant that is used widely both recreationally and as a medicine, as it has been over many centuries. Thus, it presents a brief account of the pharmacological history of cannabis and describes the cultivation and genotypic variability of this plant, the national and international regulation of cannabis and its many “cannabinoid” constituents, and the chemical structures and known pharmacological properties of some of these constituents, as well as their pharmacokinetics, metabolism, and forensic detection. In addition, it considers the benefits and risks to patients of taking cannabis-derived “phytocannabinoids” and synthetic cannabinoids that have already emerged as licensed medicines, describes pharmacological actions and effects that seem to underlie the approved therapeutic uses of these cannabinoids, and identifies an ever growing number of new wide-ranging potential clinical applications for phytocannabinoids. Also discussed in this book are the sought-after and adverse effects of cannabis when it is used as a recreational drug, how these adverse effects might be minimized, and the existence in certain countries of “coffee shops” or dispensaries from which cannabis can be purchased “legally” either for recreational use or for self-medication. The final chapter describes the emergence as recreational drugs of synthetic cannabinoids, considers whether these “designer drugs” are more harmful than cannabis, discusses the limitations of their current legal control, and describes their forensic detection.
Original languageEnglish
Place of PublicationOxford
PublisherOXFORD UNIV PRESS
Volume1
Edition1
ISBN (Print)9780199662685
DOIs
Publication statusPublished - 2014

Fingerprint

drug
medicine
self-medication
regulation
history

Keywords

  • cannabis
  • cannabinoids
  • genotypes
  • phytocannabinoids
  • tetrahydrocannabinol
  • cannabidiol
  • cannabis-based medicines
  • coffee shops
  • medical marijuana
  • designer drugs

Cite this

Handbook of Cannabis. / Pertwee, Roger G. (Editor).

1 ed. Oxford : OXFORD UNIV PRESS, 2014.

Research output: Book/ReportBook

Pertwee, Roger G. (Editor). / Handbook of Cannabis. 1 ed. Oxford : OXFORD UNIV PRESS, 2014.
@book{c011ed8809f84ea5b5983e239f027933,
title = "Handbook of Cannabis",
abstract = "This book provides a multifaceted account of cannabis, a plant that is used widely both recreationally and as a medicine, as it has been over many centuries. Thus, it presents a brief account of the pharmacological history of cannabis and describes the cultivation and genotypic variability of this plant, the national and international regulation of cannabis and its many “cannabinoid” constituents, and the chemical structures and known pharmacological properties of some of these constituents, as well as their pharmacokinetics, metabolism, and forensic detection. In addition, it considers the benefits and risks to patients of taking cannabis-derived “phytocannabinoids” and synthetic cannabinoids that have already emerged as licensed medicines, describes pharmacological actions and effects that seem to underlie the approved therapeutic uses of these cannabinoids, and identifies an ever growing number of new wide-ranging potential clinical applications for phytocannabinoids. Also discussed in this book are the sought-after and adverse effects of cannabis when it is used as a recreational drug, how these adverse effects might be minimized, and the existence in certain countries of “coffee shops” or dispensaries from which cannabis can be purchased “legally” either for recreational use or for self-medication. The final chapter describes the emergence as recreational drugs of synthetic cannabinoids, considers whether these “designer drugs” are more harmful than cannabis, discusses the limitations of their current legal control, and describes their forensic detection.",
keywords = "cannabis, cannabinoids, genotypes, phytocannabinoids, tetrahydrocannabinol, cannabidiol, cannabis-based medicines, coffee shops, medical marijuana, designer drugs",
editor = "Pertwee, {Roger G.}",
year = "2014",
doi = "10.1093/acprof:oso/9780199662685.001.0001",
language = "English",
isbn = "9780199662685",
volume = "1",
publisher = "OXFORD UNIV PRESS",
edition = "1",

}

TY - BOOK

T1 - Handbook of Cannabis

A2 - Pertwee, Roger G.

PY - 2014

Y1 - 2014

N2 - This book provides a multifaceted account of cannabis, a plant that is used widely both recreationally and as a medicine, as it has been over many centuries. Thus, it presents a brief account of the pharmacological history of cannabis and describes the cultivation and genotypic variability of this plant, the national and international regulation of cannabis and its many “cannabinoid” constituents, and the chemical structures and known pharmacological properties of some of these constituents, as well as their pharmacokinetics, metabolism, and forensic detection. In addition, it considers the benefits and risks to patients of taking cannabis-derived “phytocannabinoids” and synthetic cannabinoids that have already emerged as licensed medicines, describes pharmacological actions and effects that seem to underlie the approved therapeutic uses of these cannabinoids, and identifies an ever growing number of new wide-ranging potential clinical applications for phytocannabinoids. Also discussed in this book are the sought-after and adverse effects of cannabis when it is used as a recreational drug, how these adverse effects might be minimized, and the existence in certain countries of “coffee shops” or dispensaries from which cannabis can be purchased “legally” either for recreational use or for self-medication. The final chapter describes the emergence as recreational drugs of synthetic cannabinoids, considers whether these “designer drugs” are more harmful than cannabis, discusses the limitations of their current legal control, and describes their forensic detection.

AB - This book provides a multifaceted account of cannabis, a plant that is used widely both recreationally and as a medicine, as it has been over many centuries. Thus, it presents a brief account of the pharmacological history of cannabis and describes the cultivation and genotypic variability of this plant, the national and international regulation of cannabis and its many “cannabinoid” constituents, and the chemical structures and known pharmacological properties of some of these constituents, as well as their pharmacokinetics, metabolism, and forensic detection. In addition, it considers the benefits and risks to patients of taking cannabis-derived “phytocannabinoids” and synthetic cannabinoids that have already emerged as licensed medicines, describes pharmacological actions and effects that seem to underlie the approved therapeutic uses of these cannabinoids, and identifies an ever growing number of new wide-ranging potential clinical applications for phytocannabinoids. Also discussed in this book are the sought-after and adverse effects of cannabis when it is used as a recreational drug, how these adverse effects might be minimized, and the existence in certain countries of “coffee shops” or dispensaries from which cannabis can be purchased “legally” either for recreational use or for self-medication. The final chapter describes the emergence as recreational drugs of synthetic cannabinoids, considers whether these “designer drugs” are more harmful than cannabis, discusses the limitations of their current legal control, and describes their forensic detection.

KW - cannabis

KW - cannabinoids

KW - genotypes

KW - phytocannabinoids

KW - tetrahydrocannabinol

KW - cannabidiol

KW - cannabis-based medicines

KW - coffee shops

KW - medical marijuana

KW - designer drugs

U2 - 10.1093/acprof:oso/9780199662685.001.0001

DO - 10.1093/acprof:oso/9780199662685.001.0001

M3 - Book

SN - 9780199662685

VL - 1

BT - Handbook of Cannabis

PB - OXFORD UNIV PRESS

CY - Oxford

ER -